Carregant...
Miniatura

Tipus de document

Article

Versió

Versió publicada

Data de publicació

Llicència de publicació

cc-by-nc-nd (c)  Sociedad Española de Neurología, 2024
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/224495

Evaluation of autonomic dysfunction in hereditary transthyretin amyloidosis

Títol de la revista

Director/Tutor

ISSN de la revista

Títol del volum

Resum

Background Autonomic dysfunction is a common manifestation of hereditary transthyretin (ATTRv) amyloidosis that frequently appears early and has a major impact on disease severity, survival, and quality of life. Early detection of autonomic symptoms is paramount to avoid delayed diagnosis or misdiagnosis of ATTRv amyloidosis and thereby achieve timely interventions with novel therapies. We thus require a better understanding and recognition of the warning signs of autonomic nervous system involvement in patients with ATTRv amyloidosis. Development According to the literature and the expertise of key opinion leaders on ATTRv amyloidosis, early signs and symptoms of autonomic dysfunction often include orthostatic hypotension, gastrointestinal disturbances, and cardiac and sudomotor sympathetic denervation. Assessment methods for a rapid and accurate diagnostic thus comprise blood pressure monitoring, nutritional status evaluation, cardiac imaging techniques, and pathological and neurophysiological tests assessing small fiber function. The COMPASS-31 and Norfolk QOL-DN tests allow assessment of the severity of autonomic dysfunction and its impact on quality of life, respectively. Conclusion The screening strategy for autonomic dysfunction should involve diverse neurological and non-neurological tests to encompass the wide variety of potential manifestations of autonomic dysfunction in ATTRv amyloidosis. Further studies addressing the correlations among different tests and their prognostic value in different TTR variants are required to establish a single standardized method or the minimum set of tests needed to assess autonomic dysfunction in ATTRv amyloidosis patients.

Citació

Citació

MARTÍNEZ VALLE, Fernando, CASASNOVAS PONS, Carlos, ROMERO ACEBAL, Manuel, GALÁN DÁVILA, Lúcia. Evaluation of autonomic dysfunction in hereditary transthyretin amyloidosis. _Neurología_. 2025. Vol. 40, núm. 9, pàgs. 915-923. [consulta: 22 de gener de 2026]. ISSN: 2173-5808. [Disponible a: https://hdl.handle.net/2445/224495]

Exportar metadades

JSON - METS

Compartir registre